Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.
The Imperial College trials are not human challenge studies, hence they may not yield statistically meaningful data, even after many months. Human challenge studies, i.e Hvivo, will give meaningful results within weeks.
Good interview by Andrew Newland once again. I've followed him for a number of years now and he is a straight talking guy, dedicated and passionate about making a a success of the Parsortix technology, both for shareholders and cancer sufferers worldwide. It's great that testing and blood draws have resumed and that things are gradually getting back on track. A few months delay perhaps but as Andrew points out, if there is one thing Covid has emphasised, it's the desperate need for a liquid biopsy solution which would effectively be lockdown proof, compared to the current solid biopsy system which has also been put on hold during the pandemic, to the detriment of so many cancer sufferers who need urgent diagnosis.
Good interview by Ed. It seems as if he is very keen on shareholder communication which is something that has been desperately missing until now. His focus is more targeted also, sticking to what he knows and understands. Great to see so much recent development with Leap and Emmac. They'll be a couple of winners. Juvenescence will be a monster one day, but it's going to take a while. I think the first inflexion point for Juv could be Lygenesis though if the phase 2 trials get underway soon.
https://www.nsmedicaldevices.com/news/hvivo-antibody-test-covid-19/
Great news. Onwards and upwards!
Nice find Sportstrader, this is a really significant tweet. Not just speculation but verification that the demand is out there. OO orders to follow.
https://uk.finance.yahoo.com/quote/ptgef/
Guess some websites need updating!
Any idea why Portage is stilling trading at preconsolidation prices? I thought the 100:1 consolidation the other day would mean the share price would be about $ 11 now.
Where is the press coverage on the antibody test following the press launch yesterday? Haven't spotted any so far.
Very impressive presentation. Open Orphan goes from strength to strength.
Swab testing for whether you have the virus doesn't involve us. We're involved in antibody testing - whether you've had the virus.
https://www.ft.com/content/0e7f1aff-9323-4d82-93ff-bbc5c20514d0
https://www.theguardian.com/science/2020/may/08/who-conditionally-backs-covid-19-vaccine-trials-that-infect-people
Great news Gerry. We're all behind you!
currently up 30%. Momentum building ahead of relisting.
sorry, wrong board!
currently up 30% . Momentum building towards relist.
Great news.
Great news. Keep it coming!